NU SKIN ENTERPRISES, INC.
corporate_fare Company Profile
NU SKIN ENTERPRISES, INC. (NYSE:NUS) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 16 items for NUS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-10, rated 8/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for NUS spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Nu Skin Q2 Revenue Plunges 17%, Books $78.9M Goodwill Impairment and $167.5M Tax Charge
- Nu Skin Q2 Revenue Misses, Guides Down Sharply on Customer Exodus
- Nu Skin Q2 Revenue Plunges 17%, GAAP EPS Swings to $(5.14) on Impairment; Guides FY26 Adj. EPS $0.70-$0.90
- Nu Skin Stockholders Approve Incentive Plan, Authorizing 2.85M New Shares
- Stockholders Approve 2.85 Million Share Increase for Omnibus Incentive Plan
Financial Snapshot
Short Interest & Short Volume
8.85 days to coverFINRA reported short interest of 4,767,898 shares in NUS as of the September 15, 2026 settlement, a 5.4% increase from the prior period — about 8.8 days to cover at its recent average daily volume. On October 2, 2026, 61.8% of NUS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for NUS, detected from its recent SEC filings · based on capital-structure filings through 2026-05-29.
Incentive Plan Share Increase Approved · Significant Potential Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →